These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6324851)

  • 1. Selective inhibition of two soluble adenosine cyclic 3',5'-phosphate phosphodiesterases partially purified from calf liver.
    Yamamoto T; Lieberman F; Osborne JC; Manganiello VC; Vaughan M; Hidaka H
    Biochemistry; 1984 Feb; 23(4):670-5. PubMed ID: 6324851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The identification and characterization of two cyclic nucleotide phosphodiesterases from bovine adrenal medulla.
    Sabatine JM; Coffee CJ
    Arch Biochem Biophys; 1986 Aug; 249(1):95-105. PubMed ID: 3017224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purification and characterization of guanosine 3',5'-monophosphate-inhibited low K(m) adenosine 3',5'-monophosphate phosphodiesterase from human placental cytosolic fractions.
    LeBon TR; Kasuya J; Paxton RJ; Belfrage P; Hockman S; Manganiello VC; Fujita Yamaguchi Y
    Endocrinology; 1992 Jun; 130(6):3265-74. PubMed ID: 1317779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complex effects of inhibitors on cyclic GMP-stimulated cyclic nucleotide phosphodiesterase.
    Yamamoto T; Yamamoto S; Osborne JC; Manganiello VC; Vaughan M; Hidaka H
    J Biol Chem; 1983 Dec; 258(23):14173-7. PubMed ID: 6196360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dissimilar cyclic nucleotide phosphodiesterase activities in subcellular fractions from normal and SV40-transformed WI-38 fibroblasts.
    Nemecek GM; Butcher RW
    J Cyclic Nucleotide Res; 1979 Dec; 5(6):449-61. PubMed ID: 94064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purification of the putative hormone-sensitive cyclic AMP phosphodiesterase from rat adipose tissue using a derivative of cilostamide as a novel affinity ligand.
    Degerman E; Belfrage P; Newman AH; Rice KC; Manganiello VC
    J Biol Chem; 1987 Apr; 262(12):5797-807. PubMed ID: 3032944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular distribution of phosphodiesterase isoforms in rat cardiac tissue.
    Bode DC; Kanter JR; Brunton LL
    Circ Res; 1991 Apr; 68(4):1070-9. PubMed ID: 1849058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization and selective inhibition of cyclic nucleotide phosphodiesterase isozymes in canine tracheal smooth muscle.
    Torphy TJ; Cieslinski LB
    Mol Pharmacol; 1990 Feb; 37(2):206-14. PubMed ID: 2154670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective effects of phosphodiesterase inhibitors on different phosphodiesterases, adenosine 3',5'-monophosphate metabolism, and lipolysis in 3T3-L1 adipocytes.
    Elks ML; Manganiello VC
    Endocrinology; 1984 Oct; 115(4):1262-8. PubMed ID: 6207009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of fatty acids on activity of cGMP-stimulated cyclic nucleotide phosphodiesterase from calf liver.
    Yamamoto T; Yamamoto S; Manganiello VC; Vaughan M
    Arch Biochem Biophys; 1984 Feb; 229(1):81-9. PubMed ID: 6322693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purification and partial characterization of membrane-associated type II (cGMP-activatable) cyclic nucleotide phosphodiesterase from rabbit brain.
    Whalin ME; Strada SJ; Thompson WJ
    Biochim Biophys Acta; 1988 Oct; 972(1):79-94. PubMed ID: 2846074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclid 3':5'-nucleotide phosphodiesterase. Interconvertible multiple forms and their effects on enzyme activity and kinetics.
    Pichard AL; Cheung WY
    J Biol Chem; 1976 Sep; 251(18):5726-37. PubMed ID: 184086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation and characterization of bovine cardiac muscle cGMP-inhibited phosphodiesterase: a receptor for new cardiotonic drugs.
    Harrison SA; Reifsnyder DH; Gallis B; Cadd GG; Beavo JA
    Mol Pharmacol; 1986 May; 29(5):506-14. PubMed ID: 3010079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purification and characterization of a cyclic GMP-stimulated cyclic nucleotide phosphodiesterase from bovine tissues.
    Martins TJ; Mumby MC; Beavo JA
    J Biol Chem; 1982 Feb; 257(4):1973-9. PubMed ID: 6276403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective inhibitors of specific phosphodiesterases in intact adipocytes.
    Manganiello V; Degerman E; Elks M
    Methods Enzymol; 1988; 159():504-20. PubMed ID: 2457789
    [No Abstract]   [Full Text] [Related]  

  • 16. Purification, characterization and production of rabbit antibodies to rat liver particulate, high-affinity, cyclic AMP phosphodiesterase.
    Whitson RH; Appleman MM
    Biochim Biophys Acta; 1982 Feb; 714(2):279-91. PubMed ID: 6275911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of soluble uterine cyclic nucleotide phosphodiesterase.
    Gardner EA; Thompson WJ; Strada SJ; Stancel GM
    Biochemistry; 1978 Jul; 17(15):2995-3000. PubMed ID: 212098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of rat thymocyte proliferative response through the inhibition of different cyclic nucleotide phosphodiesterase isoforms by means of selective inhibitors and cGMP-elevating agents.
    Marcoz P; Prigent AF; Lagarde M; Nemoz G
    Mol Pharmacol; 1993 Nov; 44(5):1027-35. PubMed ID: 8246905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purification and properties of the cGMP-inhibited cAMP phosphodiesterase from bovine aortic smooth muscle.
    Rascón A; Lindgren S; Stavenow L; Belfrage P; Andersson KE; Manganiello VC; Degerman E
    Biochim Biophys Acta; 1992 Mar; 1134(2):149-56. PubMed ID: 1313303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human blood platelet 3': 5'-cyclic nucleotide phosphodiesterase. Isolation of low-Km and high-Km phosphodiesterase.
    Hidaka H; Asano T
    Biochim Biophys Acta; 1976 Apr; 429(2):485-97. PubMed ID: 177073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.